Skip to main content

Free Content Risk factors for high‐risk human papillomavirus infection in unscreened Malian women

Download Article:

You have access to the full text article on a website external to Ingenta Connect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Summary

Objective  To investigate the epidemiology of human papillomavirus (HPV) infection in Malian women, for whom cervical cancer is the most common cancer and the second most common cause of cancer‐related mortality.

Methods  Pilot study of 202 women aged 15–65 to determine the prevalence rate of high‐risk HPV infection among unscreened Malian women. Information on risk factors was collected through a standardized, structured interview and clinical examination. High‐risk (HR) HPV DNA was detected using signal amplification methods (hybrid capture II).

Results  High‐risk HPV DNA was detected in 12% of unscreened women, while visual inspection after application of acetic acid and Lugol’s iodine (VIA/VILI) identified suspicious abnormalities in 2.5% of unscreened women. Histopathological evaluation of VIA/VILI‐positive biopsies revealed no evidence of cervical intraepithelial neoplasia or cervical cancer. The majority of infections occurred among women in the 15–24 year old range. Compared to women who were married or widowed, single women were 3.5 times more likely to be infected with HR HPV.

Conclusions  The prevalence of infection with cancer causing types of HPV in this study was 12%. These prevalence estimates are consistent with what has been reported previously for other West African countries.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Language: English

Document Type: Research Article

Affiliations: 1:  Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA 2:  Institut National de Recherche en Santé Publique, Bamako, Mali 3:  Centre pour le developpement des vaccins, Bamako, Mali

Publication date: 2011-11-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more